Clinical Trial Results

Amgen
Pharma

On-body injected version of Amgen's Tepezza measures up to IV

A phase 3 trial has shown that subcutaneous injection of Amgen's Tepezza can provide comparable performance to its current route of IV administration.
Kevin Dunleavy Apr 6, 2026 9:43am
Karyopharm

Can mixed results gain an expansion for Karyopharm's Xpovio?

Mar 24, 2026 11:56am
Winrevair

Merck releases results from successful trial of Winrevair

Sep 30, 2025 8:00am
Garbage truck picking up trash on suburban street
Favicon Fierce Biotech

Biohaven trashes troriluzole in OCD after ph. 3 fail

Aug 12, 2025 2:06pm
Lilly

Eli Lilly eyes tirzepatide cardio filings after late-stage win

Aug 1, 2024 10:01am
Gilead

Gilead trumpets a Biktarvy win in HIV, hepatitis B co-infection

Aug 1, 2022 10:17am